Literature DB >> 22740393

Negative elongation factor-mediated suppression of RNA polymerase II elongation of Kaposi's sarcoma-associated herpesvirus lytic gene expression.

Zsolt Toth1, Kevin F Brulois, Lai-Yee Wong, Hye-Ra Lee, Brian Chung, Jae U Jung.   

Abstract

Genome-wide chromatin immunoprecipitation assays indicate that the promoter-proximal pausing of RNA polymerase II (RNAPII) is an important postinitiation step for gene regulation. During latent infection, the majority of Kaposi's sarcoma-associated herpesvirus (KSHV) genes is silenced via repressive histone marks on their promoters. Despite the absence of their expression during latency, however, several lytic promoters are enriched with activating histone marks, suggesting that mechanisms other than heterochromatin-mediated suppression contribute to preventing lytic gene expression. Here, we show that the RNAPII-mediated transcription of the KSHV OriLytL, K5, K6, and K7 (OriLytL-K7) lytic genes is paused at the elongation step during latency. Specifically, the RNAPII-mediated transcription is stalled by the host's negative elongation factor (NELF) at the promoter regions of OriLytL-K7 lytic genes during latency, leading to the hyperphosphorylation of the serine 5 residue and the hypophosphorylation of the serine 2 of the C-terminal domain of the RNAPII large subunit, a hallmark of stalled RNAPII. Consequently, depletion of NELF expression induced transition of stalled RNAPII into a productive transcription elongation at the promoter-proximal regions of OriLytL-K7 lytic genes, leading to their RTA-independent expression. Using an RTA-deficient recombinant KSHV, we also showed that expression of the K5, K6, and K7 lytic genes was highly inducible upon external stimuli compared to other lytic genes that lack RNAPII on their promoters during latency. These results indicate that the transcription elongation of KSHV OriLytL-K7 lytic genes is inhibited by NELF during latency, but can also be promptly reactivated in an RTA-independent manner upon external stimuli.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22740393      PMCID: PMC3446579          DOI: 10.1128/JVI.01012-12

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  71 in total

1.  Nascent RNA sequencing reveals widespread pausing and divergent initiation at human promoters.

Authors:  Leighton J Core; Joshua J Waterfall; John T Lis
Journal:  Science       Date:  2008-12-04       Impact factor: 47.728

Review 2.  RNA-driven cyclin-dependent kinase regulation: when CDK9/cyclin T subunits of P-TEFb meet their ribonucleoprotein partners.

Authors:  Annemieke A Michels; Olivier Bensaude
Journal:  Biotechnol J       Date:  2008-08       Impact factor: 4.677

3.  A comprehensive analysis of recruitment and transactivation potential of K-Rta and K-bZIP during reactivation of Kaposi's sarcoma-associated herpesvirus.

Authors:  Thomas J Ellison; Yoshihiro Izumiya; Chie Izumiya; Paul A Luciw; Hsing-Jien Kung
Journal:  Virology       Date:  2009-03-09       Impact factor: 3.616

Review 4.  Modifications of RNA polymerase II are pivotal in regulating gene expression states.

Authors:  Emily Brookes; Ana Pombo
Journal:  EMBO Rep       Date:  2009-10-16       Impact factor: 8.807

5.  Control of inducible gene expression by signal-dependent transcriptional elongation.

Authors:  Diana C Hargreaves; Tiffany Horng; Ruslan Medzhitov
Journal:  Cell       Date:  2009-07-10       Impact factor: 41.582

6.  Recruitment of cdk9 to the immediate-early viral transcriptosomes during human cytomegalovirus infection requires efficient binding to cyclin T1, a threshold level of IE2 86, and active transcription.

Authors:  Anokhi J Kapasi; Charles L Clark; Karen Tran; Deborah H Spector
Journal:  J Virol       Date:  2009-03-18       Impact factor: 5.103

7.  NELF-mediated stalling of Pol II can enhance gene expression by blocking promoter-proximal nucleosome assembly.

Authors:  Daniel A Gilchrist; Sergei Nechaev; Chanhyo Lee; Saikat Kumar B Ghosh; Jennifer B Collins; Leping Li; David S Gilmour; Karen Adelman
Journal:  Genes Dev       Date:  2008-07-15       Impact factor: 11.361

8.  Immediate mediators of the inflammatory response are poised for gene activation through RNA polymerase II stalling.

Authors:  Karen Adelman; Megan A Kennedy; Sergei Nechaev; Daniel A Gilchrist; Ginger W Muse; Yurii Chinenov; Inez Rogatsky
Journal:  Proc Natl Acad Sci U S A       Date:  2009-10-09       Impact factor: 11.205

9.  Regulation of Hox gene activity by transcriptional elongation in Drosophila.

Authors:  Vivek S Chopra; Joung-Woo Hong; Michael Levine
Journal:  Curr Biol       Date:  2009-04-02       Impact factor: 10.834

Review 10.  Promoter proximal pausing on genes in metazoans.

Authors:  David S Gilmour
Journal:  Chromosoma       Date:  2008-10-02       Impact factor: 4.316

View more
  29 in total

1.  The cellular peptidyl-prolyl cis/trans isomerase Pin1 regulates reactivation of Kaposi's sarcoma-associated herpesvirus from latency.

Authors:  Jonathan Guito; Aileen Gavina; Diana Palmeri; David M Lukac
Journal:  J Virol       Date:  2013-10-30       Impact factor: 5.103

2.  New Noncoding Lytic Transcripts Derived from the Epstein-Barr Virus Latency Origin of Replication, oriP, Are Hyperedited, Bind the Paraspeckle Protein, NONO/p54nrb, and Support Viral Lytic Transcription.

Authors:  Subing Cao; Walter Moss; Tina O'Grady; Monica Concha; Michael J Strong; Xia Wang; Yi Yu; Melody Baddoo; Kun Zhang; Claire Fewell; Zhen Lin; Yan Dong; Erik K Flemington
Journal:  J Virol       Date:  2015-04-29       Impact factor: 5.103

3.  Construction and manipulation of a new Kaposi's sarcoma-associated herpesvirus bacterial artificial chromosome clone.

Authors:  Kevin F Brulois; Heesoon Chang; Amy Si-Ying Lee; Armin Ensser; Lai-Yee Wong; Zsolt Toth; Sun Hwa Lee; Hye-Ra Lee; Jinjong Myoung; Don Ganem; Tae-Kwang Oh; Jihyun F Kim; Shou-Jiang Gao; Jae U Jung
Journal:  J Virol       Date:  2012-06-27       Impact factor: 5.103

Review 4.  Recent advances in the study of Kaposi's sarcoma-associated herpesvirus replication and pathogenesis.

Authors:  Denis Avey; Brittany Brewers; Fanxiu Zhu
Journal:  Virol Sin       Date:  2015-04-23       Impact factor: 4.327

5.  High-throughput RNA sequencing-based virome analysis of 50 lymphoma cell lines from the Cancer Cell Line Encyclopedia project.

Authors:  Subing Cao; Michael J Strong; Xia Wang; Walter N Moss; Monica Concha; Zhen Lin; Tina O'Grady; Melody Baddoo; Claire Fewell; Rolf Renne; Erik K Flemington
Journal:  J Virol       Date:  2014-10-29       Impact factor: 5.103

Review 6.  Snapshots: chromatin control of viral infection.

Authors:  David M Knipe; Paul M Lieberman; Jae U Jung; Alison A McBride; Kevin V Morris; Melanie Ott; David Margolis; Amelia Nieto; Michael Nevels; Robin J Parks; Thomas M Kristie
Journal:  Virology       Date:  2013-01-05       Impact factor: 3.616

7.  The open chromatin landscape of Kaposi's sarcoma-associated herpesvirus.

Authors:  Isaac B Hilton; Jeremy M Simon; Jason D Lieb; Ian J Davis; Blossom Damania; Dirk P Dittmer
Journal:  J Virol       Date:  2013-08-28       Impact factor: 5.103

8.  Kaposi's sarcoma-associated herpesvirus K3 and K5 ubiquitin E3 ligases have stage-specific immune evasion roles during lytic replication.

Authors:  Kevin Brulois; Zsolt Toth; Lai-Yee Wong; Pinghui Feng; Shou-Jiang Gao; Armin Ensser; Jae U Jung
Journal:  J Virol       Date:  2014-06-04       Impact factor: 5.103

9.  Inhibition of the lytic cycle of Kaposi's sarcoma-associated herpesvirus by cohesin factors following de novo infection.

Authors:  Zsolt Toth; Richard J Smindak; Bernadett Papp
Journal:  Virology       Date:  2017-12       Impact factor: 3.616

10.  The Lymphatic Cell Environment Promotes Kaposi Sarcoma Development by Prox1-Enhanced Productive Lytic Replication of Kaposi Sarcoma Herpes Virus.

Authors:  Dongwon Choi; Eunkyung Park; Kyu Eui Kim; Eunson Jung; Young Jin Seong; Luping Zhao; Shrimika Madhavan; George Daghlian; Hansuh H Lee; Patill T Daghlian; Saren Daghlian; Khoa Bui; Chester J Koh; Alex K Wong; Il-Taeg Cho; Young-Kwon Hong
Journal:  Cancer Res       Date:  2020-06-09       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.